
### [MONDO:0007462](http://purl.obolibrary.org/obo/MONDO_0007462)
**Label:** multiple sclerosis, susceptibility to

**Subclasses:** [MONDO:0013893](http://purl.obolibrary.org/obo/MONDO_0013893) (multiple sclerosis, susceptibility to, 5), [MONDO:0012958](http://purl.obolibrary.org/obo/MONDO_0012958) (MS4), [MONDO:0021571](http://purl.obolibrary.org/obo/MONDO_0021571) (multiple sclerosis, susceptibility to 1), [MONDO:0012957](http://purl.obolibrary.org/obo/MONDO_0012957) (MS3), [MONDO:0012956](http://purl.obolibrary.org/obo/MONDO_0012956) (MS2), 

**Mapped go classes:** [GO:0005031](http://purl.obolibrary.org/obo/GO_0005031) (tumor necrosis factor-activated receptor activity), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0002631](http://purl.obolibrary.org/obo/GO_0002631) (regulation of granuloma formation), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0050729](http://purl.obolibrary.org/obo/GO_0050729) (positive regulation of inflammatory response), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0006693](http://purl.obolibrary.org/obo/GO_0006693) (prostaglandin metabolic process), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0043120](http://purl.obolibrary.org/obo/GO_0043120) (tumor necrosis factor binding), [GO:0072659](http://purl.obolibrary.org/obo/GO_0072659) (protein localization to plasma membrane), [GO:1903140](http://purl.obolibrary.org/obo/GO_1903140) (regulation of establishment of endothelial barrier), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), 

**Class expressions from DL-Learner:**

- [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 56.25%
- [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis) 56.25%
- [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface) 56.25%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 56.25%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 56.25%
- [GO:0071621](http://purl.obolibrary.org/obo/GO_0071621) (granulocyte chemotaxis) and [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 56.25%
- [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis) and [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 56.25%
- [GO:0042330](http://purl.obolibrary.org/obo/GO_0042330) (taxis) and [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 56.25%
- [GO:0030595](http://purl.obolibrary.org/obo/GO_0030595) (leukocyte chemotaxis) and [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 56.25%
- [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis) and [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration) 56.25%
- Thing 51.81%
- [GO:0097530](http://purl.obolibrary.org/obo/GO_0097530) (granulocyte migration) 41.61%
- [GO:0071621](http://purl.obolibrary.org/obo/GO_0071621) (granulocyte chemotaxis) 41.61%
- [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis) and [GO:0097530](http://purl.obolibrary.org/obo/GO_0097530) (granulocyte migration) 41.61%
- [GO:0042330](http://purl.obolibrary.org/obo/GO_0042330) (taxis) and [GO:0097530](http://purl.obolibrary.org/obo/GO_0097530) (granulocyte migration) 41.61%


